Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Endovascular Repair Better for Ruptured Abdominal Aortic Aneurysms

By HospiMedica staff writers
Posted on 10 Dec 2007
A new study has found that endovascular treatment of ruptured abdominal aortic aneurysms (RAAAs) is faster and associated with less morbidity when compared with open surgical repair.

Researchers at Northwestern University (Chicago, IL, USA) compared the outcomes for 15 RAAAs treated with endovascular repair and 22 other patients who underwent standard open surgical repair that comprised a control group for comparison. More...
The procedures were performed between 2000 and 2005. Endovascular repair was made with stent graft exclusion using currently available systems. Vascular access was achieved with femoral artery cutdown in the first four endovascular repair patients; in the remaining cases, an entirely percutaneous approach was used.

The study results showed that endovascular repair achieved a technical success rate of 100%. On average, endovascular repair took 107 minutes to perform, required 6.6 units of blood, and had hospital stay of 3 days, all of which were significantly reduced compared with open surgical repair. Thirty-day mortality was also significantly lower with endovascular repair: 6.7% vs. 13.6% with surgery. In addition, no late complications, such as pseudoaneurysm or infection, were seen with endovascular repair during an average follow-up period of 12 months. The study was published in the November 2007 issue of Archives of Surgery.

"Achieving good results with this approach requires not only good technique and extensive prior experience with elective endovascular AAA repair, but a strong commitment by the hospital to support such an endeavor” said lead author Mark K. Eskandari, M.D., of the division of vascular surgery. "It requires buy-in by several specialties, an on-call team, an operating room angiosuite, and immediate availability of the endovascular devices.”


Related Links:
Northwestern University

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.